Liver metastases (LM) to predict for short overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts).
William Kevin Kelly
Research Funding - Sanofi
Susan Halabi
Research Funding - Sanofi
Michael Anthony Carducci
No relevant relationships to disclose
Daniel J. George
No relevant relationships to disclose
John Francis Mahoney
No relevant relationships to disclose
Walter Michael Stadler
Research Funding - Roche/Genentech
Michael J. Morris
Consultant or Advisory Role - Sanofi
Research Funding - Sanofi
Philip W. Kantoff
No relevant relationships to disclose
J. P. Monk
Research Funding - Sanofi
Eric Jay Small
No relevant relationships to disclose